PDCD1 and melanoma: In two cohorts of patients with advanced melanoma treated with ICI, anti-PD-1, and anti-TIM-3, there was a strong correlation between the proportions of PD-1hiCTLA-4hi cells within the tumor-infiltrating CD8+ T cell subset and the ORR and PFS [85].